KATELYN WILLIAMS: Open Payments
NPI 1447898226 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 42 payments from 12 companies in 2025. Trend: 2023 $931 · 2024 $1,475 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $225 |
| PFIZER INC. | 9 | $218 |
| Amgen Inc. | 3 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $59 |
| Merck Sharp & Dohme LLC | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Edwards Lifesciences Corporation | 1 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
Products named: LEQVIO, ELIQUIS, REPATHA, JARDIANCE, LifeVest, VERQUVO, WAINUA, CAMZYOS.
Industry payments across OR — which companies pay providers there.
